Flputnam Investment Management CO Gilead Sciences, Inc. Transaction History

Flputnam Investment Management CO

$5.29 Billion
Q2 2024

A detailed history of Flputnam Investment Management CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Flputnam Investment Management CO holds 5,280 shares of GILD stock, worth $444,417. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,280

Previous 3,074 71.76%

Holding current value

$444,417

Previous $225,000 60.89%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $139,308 - $160,773	2,206 Added 71.76%	5,280 $362,000
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $214,453 - $261,520	-2,996 Reduced 49.36%	3,074 $225,000
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $60,521 - $68,632	826 Added 15.75%	6,070 $491,000
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $123,553 - $134,799	1,671 Added 46.77%	5,244 $392,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $32,076 - $36,587	422 Added 13.39%	3,573 $275,000
Q1 2023 Apr 27, 2023	BUY	$77.31 - $88.08 $58,987 - $67,205	763 Added 31.95%	3,151 $261,000
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $148,820 - $213,654	2,388 New	2,388 $205,000
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $305,036 - $333,296	-4,806 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $270,720 - $308,891	-4,512 Reduced 48.42%	4,806 $311,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $3,512 - $4,002	-62 Reduced 0.66%	9,318 $543,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $82,282 - $103,456	-1,325 Reduced 12.38%	9,380 $593,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $156,760 - $182,028	2,167 Added 25.38%	10,705 $824,000
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $88,621 - $113,511	-1,415 Reduced 14.22%	8,538 $638,000
Q4 2019 Jan 30, 2020	BUY	$61.62 - $67.78 $106,725 - $117,394	1,732 Added 21.07%	9,953 $647,000
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $131,020 - $144,624	2,096 Added 34.22%	8,221 $521,000
Q2 2019 Jul 25, 2019	BUY	$61.87 - $69.38 $21,407 - $24,005	346 Added 5.99%	6,125 $414,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $11,630 - $13,029	186 Added 3.33%	5,779 $376,000
Q4 2018 Feb 22, 2019	BUY	$60.54 - $79.0 $48,553 - $63,358	802 Added 16.74%	5,593 $350,000
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $15,396 - $17,046	216 Added 4.72%	4,791 $370,000
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $242,197 - $282,513	-3,733 Reduced 44.93%	4,575 $324,000
Q1 2018 May 01, 2018	SELL	$72.84 - $88.8 $867,014 - $1.06 Million	-11,903 Reduced 58.89%	8,308 $626,000
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $156,885 - $184,161	-2,205 Reduced 9.84%	20,211 $1.45 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $1.62 Million - $1.92 Million	22,416	22,416 $1.82 Million

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Account

Flputnam Investment Management CO Gilead Sciences, Inc. Transaction History